File Name
-
..——
-
125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf7.08MB2022-05-04 13:28:21125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf7.44MB2022-05-04 13:27:24125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf2.33MB2022-05-04 13:26:48125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf1.99MB2022-05-04 13:26:21125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf2.01MB2022-05-04 13:32:04125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf1.09MB2022-05-04 13:31:33125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf634.42KB2022-05-04 13:29:27125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf6.28MB2022-05-04 13:28:56125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf91.06MB2022-05-04 13:09:31125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf1.21MB2022-05-04 12:58:54125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf2.56MB2022-05-04 12:58:06125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf1.47MB2022-05-04 12:56:51125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf10.46MB2022-05-04 12:57:31125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf41.63MB2022-05-04 12:49:36125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf9.10MB2022-05-04 12:40:29125742_S1_M5_5351_bnt162-01-interim3-sap.pdf2.91MB2022-05-04 13:00:36125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf1.97MB2022-05-04 13:00:10125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf1.52MB2022-05-04 12:59:39125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf3.71MB2022-05-04 12:59:16125742_S1_M5_5351_bnt162-01_10010.pdf1.46MB2022-05-04 13:32:56125742_S1_M5_5351_bnt162-01_10075.pdf1.59MB2022-05-04 13:32:28125742_S1_M5_5351_bnt162-01_20116.pdf1.51MB2022-05-04 13:34:04125742_S1_M5_5351_bnt162-01_20215.pdf1.63MB2022-05-04 13:33:19125742_S1_M5_5351_bnt162-01_20242.pdf1.66MB2022-05-04 13:33:43125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf64.92MB2022-05-04 12:35:32125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf5.39MB2022-05-04 12:30:36125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf11.95MB2022-05-04 12:29:54125742_S1_M5_CRF_c4591001-1001-10011093.pdf2.62MB2022-05-04 12:19:51125742_S1_M5_CRF_c4591001-1001-10011100.pdf2.13MB2022-05-04 12:18:54125742_S1_M5_CRF_c4591001-1001-10011135.pdf1.42MB2022-05-04 12:19:22125742_S1_M5_CRF_c4591001-1003-10031038.pdf2.71MB2022-05-04 12:18:31125742_S1_M5_CRF_c4591001-1003-10031065.pdf2.66MB2022-05-04 12:24:03125742_S1_M5_CRF_c4591001-1003-10031111.pdf1.71MB2022-05-04 12:23:40125742_S1_M5_CRF_c4591001-1003-10031113.pdf3.22MB2022-05-04 12:23:17125742_S1_M5_CRF_c4591001-1003-10031149.pdf1.63MB2022-05-04 12:22:44125742_S1_M5_CRF_c4591001-1003-10031186.pdf2.42MB2022-05-04 12:22:06125742_S1_M5_CRF_c4591001-1003-10031197.pdf1.48MB2022-05-04 12:20:40125742_S1_M5_CRF_c4591001-1003-10031207.pdf1.44MB2022-05-04 12:21:05125742_S1_M5_CRF_c4591001-1005-10051047.pdf1.39MB2022-05-04 12:20:12125742_S1_M5_CRF_c4591001-1005-10051054.pdf1.88MB2022-05-04 12:17:40125742_S1_M5_CRF_c4591001-1005-10051069.pdf1.46MB2022-05-04 12:18:06125742_S1_M5_CRF_c4591001-1005-10051214.pdf1.38MB2022-05-04 12:16:54125742_S1_M5_CRF_c4591001-1005-10051293.pdf2.41MB2022-05-04 12:16:07125742_S1_M5_CRF_c4591001-1005-10051347.pdf1.45MB2022-05-04 12:16:29125742_S1_M5_CRF_c4591001-1005-10051387.pdf1.69MB2022-05-04 12:15:42125742_S1_M5_CRF_c4591001-1005-10051411.pdf1.35MB2022-05-04 12:15:19125742_S1_M5_CRF_c4591001-1006-10061020.pdf1.52MB2022-05-04 12:08:55125742_S1_M5_CRF_c4591001-1006-10061040.pdf3.82MB2022-05-04 12:07:57125742_S1_M5_CRF_c4591001-1006-10061052.pdf2.12MB2022-05-04 12:08:27125742_S1_M5_CRF_c4591001-1006-10061094.pdf2.08MB2022-05-04 12:07:29125742_S1_M5_CRF_c4591001-1006-10061098.pdf1.57MB2022-05-04 12:06:39125742_S1_M5_CRF_c4591001-1006-10061176.pdf2.63MB2022-05-04 12:07:04125742_S1_M5_bnt162-01-A-adrg.pdf891.07KB2022-05-04 12:24:33125742_S1_M5_bnt162-01-S-acrf.pdf1.40MB2022-05-04 12:26:33125742_S1_M5_bnt162-01-S-csdrg.pdf1.20MB2022-05-04 12:29:05125742_S1_M5_c4591001-S-Supp-acrf.pdf2.89MB2022-05-04 12:25:29125742_S1_M5_c4591001-S-acrf.pdf2.89MB2022-05-04 12:27:45125742_S1_M5_c4591001-S-csdrg.pdf1.43MB2022-05-04 12:24:55FDA-CBER-2021-5683-0058316-to-0058458_125742_S1_M5_c4591001-A-Supp-define.xml691.95KB2022-05-04 12:06:15FDA-CBER-2021-5683-0058459-to-0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl183.26KB2022-05-04 12:06:03FDA-CBER-2021-5683-0058479-to-0058594_125742_S1_M5_c4591001-S-define.xml904.18KB2022-05-04 12:06:07FDA-CBER-2021-5683-0058595-to-0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl183.26KB2022-05-04 12:04:06FDA-CBER-2021-5683-0058615-to-0058652_125742_S1_M5_c4591001-S-Supp-define.xml299.80KB2022-05-04 12:03:47FDA-CBER-2021-5683-0058653-to-0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl183.26KB2022-05-04 12:03:54FDA-CBER-2021-5683-0058676-to-0058794_125742_S1_M5_bnt162-01-A-define.xml828.13KB2022-05-04 12:03:58FDA-CBER-2021-5683-0058795-to-0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl183.26KB2022-05-04 12:03:30FDA-CBER-2021-5683-0058829-to-0058954_125742_S1_M5_bnt162-01-S-define.xml0.96MB2022-05-04 12:03:39FDA-CBER-2021-5683-0058955-to-0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl183.26KB2022-05-04 12:03:20FDA-CBER-2021-5683-0059000-to-0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt394.37MB2022-05-04 12:01:14FDA-CBER-2021-5683-0065774-to-0066700_125742_S1_M5_c4591001-A-D-addv.xpt43.54MB2022-05-04 12:03:06FDA-CBER-2021-5683-0066701-to-0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt3.42GB2022-05-04 11:59:43FDA-CBER-2021-5683-0123168-to-0126026_125742_S1_M5_c4591001-A-D-adva.xpt162.85MB2022-05-04 12:00:43